Clinical Trial Update: An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis [Phase 2]

View source ↗

Summary

A Phase 2 study of the investigational drug TPST-1495 in patients with Familial Adenomatous Polyposis and colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Familial Adenomatous Polyposis

Drugs mentioned

• TPST-1495 (TPST-1495)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Carcinoma, Familial Adenomatous Polyposis | Phase 2 | Status: RECRUITING